Refining checklist-based screening for transthyretin cardiac amyloidosis: methodological and pathophysiological considerations. Author's reply

Scritto il 27/05/2026
da Alberto Pérez-Nieva

No abstract

Eur J Intern Med. 2026 May 27:106975. doi: 10.1016/j.ejim.2026.106975. Online ahead of print.

NO ABSTRACT

PMID:42203534 | DOI:10.1016/j.ejim.2026.106975